A comparison of the effects of Triamcinolone and magnesium sulfate in caudal neuroplasty

Phase 3

Recruiting

• Conditions: low back pain.; Low back pain

• Registration Number: IRCT20111102007984N29
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 25 February 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Chronic low back pain more than six months +/- radiculopathy
Moderate to severe pain score (> 3, based on the Visual Analog Scale)
Being at the age of 40-70 years
Inadequate response to conservative and physiotherapy treatments after three months
American Anesthesiologists Classification (ASA) I-II
Disc protrusion in MRI

Exclusion Criteria

Severe canal stenosis (more than two thirds in axial MRI view)
Sequestrated disc (fragmented)
Decreased disc height more than 60%
Sever spinal deformity
Spinal tumors
Vertebral fracture
Spondylolisthesis Grade>2
Local or systemic infection
Taking anticoagulants
Drug abuse
History of drug reaction
Sever psychological disorders
Pregnancy and lactation
Severe or sudden neurological deficit such as urinary or fecal incontinence
Body Mass Index (BMI) > 35
Patient's refusal
Diabetes mellitus
MRI contraindications (cardiac pacemaker, defibrillator, aortic aneurysm clips)
Impossible prone positioning

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ow back pain. Timepoint: Before injection,two weeks,1,3 and 6 months after intervention. Method of measurement: pain score measured with visual analogue scale in Questionnaire.